[go: up one dir, main page]

AR127559A1 - Compuestos, composiciones y métodos - Google Patents

Compuestos, composiciones y métodos

Info

Publication number
AR127559A1
AR127559A1 ARP220103009A ARP220103009A AR127559A1 AR 127559 A1 AR127559 A1 AR 127559A1 AR P220103009 A ARP220103009 A AR P220103009A AR P220103009 A ARP220103009 A AR P220103009A AR 127559 A1 AR127559 A1 AR 127559A1
Authority
AR
Argentina
Prior art keywords
compositions
compounds
methods
compound
pharmaceutically acceptable
Prior art date
Application number
ARP220103009A
Other languages
English (en)
Inventor
Anjali Pandey
Biswajit Kalita
Athisayamani Jeyaraj Duraiswamy
Original Assignee
Aria Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aria Pharmaceuticals Inc filed Critical Aria Pharmaceuticals Inc
Publication of AR127559A1 publication Critical patent/AR127559A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Un compuesto de la fórmula (1). Reivindicación 35: Una composición farmacéutica que comprende un compuesto de cualquier reivindicación anterior, o una sal farmacéuticamente aceptable, estereoisómero, mezcla de estereoisómeros o profármaco de este, y un portador farmacéuticamente aceptable.
ARP220103009A 2021-11-02 2022-11-02 Compuestos, composiciones y métodos AR127559A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US202163274916P 2021-11-02 2021-11-02

Publications (1)

Publication Number Publication Date
AR127559A1 true AR127559A1 (es) 2024-02-07

Family

ID=84364211

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP220103009A AR127559A1 (es) 2021-11-02 2022-11-02 Compuestos, composiciones y métodos

Country Status (3)

Country Link
AR (1) AR127559A1 (es)
TW (1) TW202334135A (es)
WO (1) WO2023081666A1 (es)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2499465A1 (en) * 2002-07-16 2004-01-22 Amura Therapeutics Limited Biologically active compounds
US7834021B2 (en) * 2002-11-27 2010-11-16 Incyte Corporation 3-aminopyrrolidine derivatives as modulators of chemokine receptors
EP2685828A4 (en) * 2011-03-17 2014-08-13 Merck Sharp & Dohme SUBSTITUTED 3-AZABICYCLO [3,1,0-] HEXAN DERIVATIVES AS CCR2 ANTAGONISTS

Also Published As

Publication number Publication date
TW202334135A (zh) 2023-09-01
WO2023081666A1 (en) 2023-05-11

Similar Documents

Publication Publication Date Title
MX2025004220A (es) Compuestos triciclicos y sus usos
ECSP20044709A (es) Inhibidores de sarcómero cardíaco
ZA202200519B (en) Piperidinyl-methyl-purineamines as nsd2 inhibitors and anti-cancer agents
AR056873A1 (es) Derivados de pirazolopirimidinas como inhibidores de quinasa dependientes de ciclina, composiciones farmaceuticas
MX2022004450A (es) Aminas de heteroaril-bifenilo para el tratamiento de enfermedades pd-l1.
MX2020009530A (es) Inhibidores de la o-glicoproteína-2-acetamido-2-desoxi-3-dglicopir anosidasa.
MX2024003738A (es) Formas solidas, composiciones farmaceuticas y preparacion de compuestos de eter macrociclico heteroaromatico.
DOP2024000146A (es) Inhibidores de parp7
WO2022104153A3 (en) Compounds and methods for treating viral infections
MX2024012470A (es) Inhibidores de cinasas dependientes de ciclina 9 (cdk9)
MX2021003232A (es) Inhibidores de o-glicoproteina-2-acetamido-2-desoxi-3-d-glucopiran osidasa.
AR133240A1 (es) Compuestos, composiciones y métodos
AR133241A1 (es) Compuestos, composiciones y métodos
CO2022008616A2 (es) Composición farmacéutica oral que comprende compuesto de carbamato y método de preparación para la misma
EA202192530A1 (ru) Соединения, композиции и способы
AR116428A1 (es) Compuestos de 6-fluoro-2-metilbenzo[d]tiazol-5-ilo
CO2025004701A2 (es) Métodos de tratamiento del cáncer usando derivados de isoquinolina o 6-aza-quinolina
DOP2022000073A (es) Derivados de 2-azaspiro[3,4]octano como agonistas de m4
CR20230218A (es) Nuevos derivados de indazol acetileno
AR127559A1 (es) Compuestos, composiciones y métodos
AR132818A1 (es) Compuestos para la degradación de la cinasa egfr
WO2020251871A3 (en) Novel substituted tetrahydroquinolin compounds as indoleamine 2,3-dioxygenase (ido) inhibitors
MX2024008745A (es) Compuesto derivado de 1,3-benzodioxol y composicion farmaceutica que comprende el mismo.
AR130303A1 (es) Compuestos de pirazolilsulfonamida y su uso terapéutico
GEAP202516765A (en) Exatecan-derived adc linker-payloads, pharmaceutical compositions, and uses thereof

Legal Events

Date Code Title Description
FB Suspension of granting procedure